Michael Lau's Form 3 Filing as CEO of Anbio Biotechnology

This is a Form 3 filing by Michael Lau, who has been appointed as CEO of Anbio Biotechnology (ticker: NNNN). The filing represents an initial statement of beneficial ownership of securities, indicating that Mr. Lau has no securities owned as of the reporting date of March 18, 2026. The filing was signed on April 8, 2026, and confirms Mr. Lau's position as an officer of the company with the title of CEO. The filing shows that he is not a director, 10% owner, or other type of reporting person. The address provided for Mr. Lau is in Frankfurt, Germany, indicating international executive leadership for the biotechnology company. Form 3 filings are required when individuals become officers, directors, or beneficial owners of a company's securities, and this filing establishes the baseline ownership position for the new CEO.